c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition. (Q39511529)
Jump to navigation
Jump to search
scientific article published on 15 September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition. |
scientific article published on 15 September 2011 |
Statements
c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition (English)
Ziqiu Wang
Meifang Wang
Aldo Cavallini
Rosalba D'Alessandro
Maria Gratzia Refolo
15 September 2011